Cost-effectiveness and value-based prices of the 9-valent human papillomavirus vaccine for the prevention of cervical cancer in China: an economic modelling analysis

OBJECTIVES: To evaluate the cost-effectiveness of the 9-valent human papillomavirus (HPV) vaccine for the prevention of cervical cancer in China. DESIGN: Health economic modelling using the Papillomavirus Rapid Interface for Modelling and Economics (PRIME) model populated with China-specific data. S...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Y, Ni, Weiyi, Wu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886925/
https://www.ncbi.nlm.nih.gov/pubmed/31767588
http://dx.doi.org/10.1136/bmjopen-2019-031186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886925/
https://www.ncbi.nlm.nih.gov/pubmed/31767588
http://dx.doi.org/10.1136/bmjopen-2019-031186

Ejemplares similares